KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Takeda Pharmaceutical (TAK) Debt Ratio (2018 - 2025)

Takeda Pharmaceutical (TAK) has 3 years of Debt Ratio data on record, last reported at 0.33 in Q1 2022.

  • For Q1 2022, Debt Ratio rose 455.03% year-over-year to 0.33; the TTM value through Mar 2025 reached 0.06, up 110.19%, while the annual FY2022 figure was 0.33, 455.03% up from the prior year.
  • Debt Ratio reached 0.33 in Q1 2022 per TAK's latest filing, up from 0.06 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.33 in Q1 2022 and bottomed at 0.06 in Q1 2021.
  • Average Debt Ratio over 3 years is 0.16, with a median of 0.09 recorded in 2019.
  • The widest YoY moves for Debt Ratio: up 455.03% in 2022, down 455.03% in 2022.
  • A 3-year view of Debt Ratio shows it stood at 0.09 in 2019, then plummeted by 33.24% to 0.06 in 2021, then skyrocketed by 455.03% to 0.33 in 2022.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.33 in Q1 2022, 0.06 in Q1 2021, and 0.09 in Q1 2019.